Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Sep 4 - Sep 9
BPC-157 is a 15-residue, 1419.53 g/mol pentadecapeptide whose mechanistic literature centres on local angiogenic signalling, Hsieh and colleagues (J Mol Med, 2017) reported upregulation and internalisation of VEGFR2 in human endothelial cells, and Chang and colleagues (J Appl Physiol, 2011) reported increased FAK and paxillin phosphorylation with greater outgrowth and migration in cultured rat tendon fibroblasts
N.E.R.V.E
Disclaimer: Healthletic BPC-157 is not intended to diagnose, treat, cure, or prevent any disease
Cardioprotective Effects: Research indicates that this treatment can significantly reduce the size of a myocardial infarction, enhance healing following an injury, and promote blood vessel formation and vascular growth to improve blood flow
US$ 26.68
US$ 24.11
US$ 22.01
US$ 20.82
